Kegg Pathway: Apoptosis

KEGG ID: 04210

Reference Diagram

KEGG Diagram for Apoptosis

Rat

There are 75 IPI Records from this pathway found in Rattus norvegicus.

Location of Apoptosis proteins on Rat Genome

IPI Record Position
1: Akt1 6:137640482-137657552
2: Akt2 1:82686233-82726544
3: Akt3 13:92807672-92924984
4: Apaf1 7:27934653-28018255
5: Bad 1:209617373-209626292
6: Bax 1:95932860-95938176
7: Bcl2 13:12730736-12905108
8: Bcl2l1 3:143129087-143180199
9: Bid 4:157296383-157318481
10: Birc2 8:4649559-4668104
11: Birc3 8:4682202-4692389
12: Birc4 X:3011520-3055048
13: Capn1 1:208620284-208645007
14: Capn2 13:98476339-98524037
15: Casp12 8:2083906-2110511
16: Casp3 16:48944226-48962420
17: Casp6 2:227361538-227373844
18: Casp7 1:262689300-262721591
19: Casp8 9:57389353-57437803
20: Casp9_v1 5:160704225-160721802
21: Cflar 9:57309836-57361458
22: Chp 3:106066389-106101638
23: Chuk_predicted 1:249122847-249157179
24: Csf2rb1 7:116237279-116271993
25: Cycs 18:63216914-63217231
26: Dffa 5:166179130-166190746
27: Dffb 5:170750825-170762034
28: Fadd 1:205009564-205012786
29: Faslg 13:77472950-77480210
30: Ikbkb 16:73805082-73858088
31: Ikbkg X:160407166-160420190
32: Il1a 3:116913612-116923352
33: Il1b 3:116964427-116970887
34: Il1r1 9:39433337-39473646
35: Il1rap 11:76092840-76222495
36: Il3 10:39684691-39687041
37: IPI00369732 8:56895083-56994044
38: Irak1_predicted X:159959294-159969180
39: Irak2 4:149543029-149616865
40: Irak3_predicted 7:59409198-59467682
41: Irak4_predicted 7:133054573-133081527
42: Map3k14_predicted 10:92406829-92430131
43: Myd88 8:124299725-124303798
44: Nfkb1 2:233091020-233187501
45: Nfkb2 1:251521559-251527815
46: Nfkbia 6:75729302-75732474
47: Ngfb 2:197621794-197632945
48: Ntrk1 2:179838740-179855545
49: Pdcd8 X:134868878-134908180
50: Pik3ca 2:118640277-118670170
51: Pik3cb 8:103886682-103957112
52: Pik3cd_predicted 5:166735338-166750186
53: Pik3cg_predicted 6:50444793-50477111
54: Pik3r1 2:32602673-32675350
55: Pik3r2 16:19171101-19179650
56: Pik3r3 5:136497494-136566473
57: Ppp3ca 2:234333405-234408670
58: Ppp3cb 15:4003159-4022737
59: Ppp3cc 15:50616841-50666010
60: Ppp3r1 14:98047333-98131590
61: Ppp3r2 5:66423374-66424371
62: Prkaca 19:25837118-25864844
63: Prkar1a :-
64: Prkar2a 8:113746382-113805476
65: Prkar2b 6:50234982-50325293
66: Rela 1:208263316-208272419
67: RGD1563261_predicted 10:55182226-55247889
68: Ripk1_predicted 17:37185782-37211023
69: Tnf 20:3661000-3663618
70: Tnfrsf10b_predicted 15:50141256-50162287
71: Tnfrsf1a 4:162172542-162185252
72: Tnfrsf6 1:238259337-238274745
73: Tnfsf10 2:113204304-113221562
74: Tp53 10:56399668-56411149
75: Tradd 19:35072870-35075251

Mouse

There are 75 IPI Records from this pathway found in Mus musculus.

Location of Apoptosis proteins on Mouse Genome

IPI Record Position
1: Aifm1 X:44719571-44758053
2: Akt1 :-
3: Akt2 7:27300516-27348213
4: Akt3 1:178862039-178967772
5: Apaf1 10:90419117-90512538
6: Atm 9:53201763-53296362
7: Bad 19:7008905-7018937
8: Bax 7:45329742-45334871
9: Bcl2l1 2:152458757-152523123
10: Bid 6:120858471-120882453
11: Birc2 9:7818749-7835790
12: Birc3 9:7849220-7873545
13: Birc4 X:38315952-38350134
14: Capn1 19:5988546-6015163
15: Capn2 1:184306854-184354029
16: Casp12 9:5345502-5373034
17: Casp3 8:48116235-48137523
18: Casp6 3:129897501-129905595
19: Casp7 19:56457666-56494345
20: Casp8 1:58739978-58791553
21: Casp9 4:141065688-141088051
22: Cflar 1:58656054-58699719
23: Chuk 19:44126647-44160756
24: Csf2rb 15:78153275-78177290
25: Csf2rb2 15:78109765-78132858
26: Dffa 4:147947946-147964450
27: Dffb 4:152808255-152818926
28: Endog 2:29993533-29996078
29: Fadd 7:144387713-144391826
30: Fas 19:34356663-34393767
31: Fasl 1:163617366-163625172
32: Ikbkb 8:24124758-24172108
33: Ikbkg X:70677332-70704240
34: Il1a 2:128991051-129001413
35: Il1b 2:129056011-129062561
36: Il1r1 1:40169626-40260723
37: Il1rap 16:26497062-26640497
38: Il3 11:54108726-54110700
39: Il3ra 14:13139762-13148759
40: Irak1 X:70266646-70276641
41: Irak2 6:113604278-113660787
42: Irak3 10:119544714-119604597
43: Irak4 15:94371840-94396486
44: Map3k14 11:103035854-103083835
45: Myd88 9:119184642-119188700
46: Nfkb1 3:135292997-135605172
47: Nfkb2 19:46358111-46365401
48: Nfkbia 12:56407731-56410725
49: Ngfb 3:102598989-102650066
50: Ntrk1 3:87864171-87881089
51: Pik3ca 3:32627755-32654380
52: Pik3cb 9:98847754-98949439
53: Pik3cd 4:148492970-148542498
54: Pik3cg 12:32758720-32793858
55: Pik3r1 13:102781018-102868441
56: Pik3r2 8:73697168-73705691
57: Pik3r3 4:115719846-115800988
58: Pik3r5 11:68248320-68314041
59: Ppp3ca 3:136608220-136874773
60: Ppp3cb 14:19288592-19335096
61: Ppp3cc 14:68953164-69002587
62: Ppp3r1 :-
63: Ppp3r2 4:49699847-49703083
64: Prkaca 8:86863093-86889980
65: Prkacb 3:146666960-146750346
66: Prkar1a 11:109466334-109485746
67: Prkar1b 5:139270948-139383333
68: Prkar2a 9:108549547-108606747
69: Prkar2b 12:32543731-32646499
70: Rela 19:5637490-5648130
71: Ripk1 13:34010339-34042635
72: Tnf 17:34807442-34810048
73: Tnfrsf10b 14:68502562-68518625
74: Tnfrsf1a 6:125315374-125328103
75: Tnfsf10 3:27508150-27530738
76: Tradd 8:108147415-108153738
77: Traf2 2:25339991-25368903
78: Trp53 11:69396600-69407992

Human

There are 75 IPI Records from this pathway found in Homo sapiens.

Location of Apoptosis proteins on Human Genome

IPI Record Position
1: AIFM1 X:129091018-129127489
2: AKT1 14:104306734-104333125
3: AKT2 19:45430084-45483036
4: AKT3 1:241718158-242080053
5: APAF1 12:97563209-97653335
6: ATM 11:107598769-107745036
7: BAD 11:63793878-63808740
8: BAX 19:54149929-54156864
9: BCL2 18:58941559-59137593
10: BCL2L1 20:29715916-29774366
11: BID 22:16596908-16637431
12: BIRC2 11:101723176-101754604
13: BIRC3 11:101693404-101713658
14: BIRC4 X:122821558-122875510
15: CAPN1 11:64705792-64736048
16: CAPN2 1:221966657-222030343
17: CASP10 2:201756100-201802372
18: CASP3 4:185785845-185807623
19: CASP6 4:110829234-110844078
20: CASP7 10:115428953-115480652
21: CASP8 2:201806426-201860677
22: CASP9 1:15687322-15723527
23: CFLAR 2:201689135-201737246
24: CHP 15:39310729-39361369
25: CSF2RB 22:35648168-35664764
26: CYCS 7:25124802-25131480
27: DFFA 1:10439166-10455200
28: DFFB 1:3763705-3791853
29: ENDOG 9:130620574-130624777
30: FADD 11:69726917-69731134
31: FAS 10:90739206-90765521
32: FASLG 1:170894777-170902637
33: IKBKB 8:42247986-42309130
34: IKBKG X:153423653-153446455
35: IL1A 2:113247966-113259442
36: IL1B 2:113303808-113310827
37: IL1R1 2:102125678-102159788
38: IL1RAP 3:191714585-191858537
39: IL3 5:131424121-131426796
40: IL3RA X:1415509-1461581
41: IRAK1 X:152929145-152938625
42: IRAK2 3:10181563-10260427
43: IRAK3 12:64869270-64928684
44: IRAK4 12:42439067-42468164
45: MAP3K14 17:40696278-40750148
46: MYD88 3:38155157-38159514
47: NFKB1 4:103641518-103757506
48: NFKB2 10:104144320-104152271
49: NFKBIA 14:34940475-34943703
50: NGFB 1:115630060-115682380
51: NTRK1 1:155052166-155118266
52: PIK3CA 3:180349005-180435189
53: PIK3CB 3:139856921-139960875
54: PIK3CD 1:9634390-9711564
55: PIK3CG 7:106292977-106334801
56: PIK3R1 5:67547360-67633403
57: PIK3R2 19:18125016-18142343
58: PIK3R3 1:46278399-46371054
59: PIK3R5 17:8722953-8756559
60: PPP3CA 4:102163610-102487376
61: PPP3CB 10:74866192-74925765
62: PPP3CC 8:22354541-22454580
63: PPP3R1 :-
64: PPP3R2 9:103393718-103397104
65: PRKACA 19:14063509-14089559
66: PRKACB 1:84316329-84476769
67: PRKACG 9:70817241-70818849
68: PRKAR1A 17:64019705-64040503
69: PRKAR1B 7:555905-733813
70: PRKAR2A 3:48762099-48860274
71: PRKAR2B 7:106472375-106589491
72: RELA 11:65177649-65186959
73: RIPK1 6:3009212-3060418
74: TNF 6:31678016-31680778
75: TNFRSF10A 8:23104009-23138584
76: TNFRSF10B 8:22933598-22982637
77: TNFRSF10C 8:23016377-23030895
78: TNFRSF10D 8:23049046-23077488
79: TNFRSF1A 12:6308185-6321522
80: TNFSF10 3:173706159-173723963
81: TP53 17:7512464-7531642
82: TRADD 16:65745605-65751306
83: TRAF2 9:138900786-138940887

Google Scholar

Recent Literature

High-throughput detection of NFkappaB activity using a sensitive oligo-based chemiluminescent ELISA.

Int J Cancer. 2009 Nov 18;
Bhattacharya N, Sarno A, Idler IS, Führer M, Zenz T, Döhner H, Stilgenbauer S, Mertens D

Contemporary research on cellular signaling has undergone a shift of focus from qualitative measurements of single signaling pathways to high-throughput quantitation of comprehensive signaling networks. Notably, NFkappaB is a family of transcription factors involved in immune and inflammatory responses, developmental processes, cellular growth and Apoptosis, and is deregulated in a number of disease states. We have established a chemiluminescent oligonucleotide-based ELISA (co-ELISA) that is simple and quantitative. In contrast to currently used assays, it allows quantitation of all NFkappaB components (i.e. RelA, p50, p52, RelB, and c-Rel). In addition, it can make use of whole extract and does not require cumbersome nuclear/cytosolic fractionation, saving time and resources. Co-ELISA has a 3.5- to 43-fold higher signal-over-noise ratio than currently available assays, while the percent relative standard deviation is 3-to 6-fold lower. Also, the novel method is faster than EMSA, not restricted to transfectable cells as is the case for luciferase reporter assays, and ten times more cost-efficient than commercially available ELISA assays. Co-ELISA is a sensitive, fast, and cost-efficient quantitation method for all DNA-binding NFkappaB proteins that can be used in high-throughput experimentation. (c) 2009 UICC.

Gold Nanoparticles Capped with Polyethyleneimine for Enhanced siRNA Delivery.

Small. 2009 Nov 18;
Song WJ, Du JZ, Sun TM, Zhang PZ, Wang J

An efficient and safe delivery system for small interfering RNA (siRNA) is required for clinical application of RNA interfering therapeutics. Polyethyleneimine (PEI)-capped gold nanoparticles (AuNPs) are successfully manufactured using PEI as the reductant and stabilizer, which bind siRNA at an appropriate weight ratio by electrostatic interaction and result in well-dispersed nanoparticles with uniform structure and narrow size distribution. With siRNA binding, PEI-capped AuNPs induce more significant and enhanced reduction in targeted green fluorescent protein expression in MDA-MB-435s cells, though more internalized PEI/siRNA complexes in cells are evidenced by confocal laser scanning microscopy observation and fluorescence-activated cell sorting analyses. PEI-capped AuNPs/siRNA targeting endogenous cell-cycle kinase, an oncogene polo-like kinase 1 (PLK1), display significant gene expression knockdown and induce enhanced cell Apoptosis, whereas it is not obvious when the cells are treated with PLK1 siRNA using PEI as the carrier. Without exhibiting cellular toxicity, PEI-capped AuNPs appear to be suitable as a potential carrier for intracellular siRNA delivery.

Morphological and biochemical patterns in skeletal muscle Apoptosis.

Histol Histopathol. 2010 Jan; 25(1): 21-32
D'Emilio A, Biagiotti L, Burattini S, Battistelli M, Canonico B, Evangelisti C, Ferri P, Papa S, Martelli AM, Falcieri E

Some neuromuscular disorders, such as Duchenne muscular dystrophy, hereditary inclusion body myopathy, malignant hyperthermia, alcoholic myopathy and mitochondrial myopathies are characterized by oxidative stress and loss of muscle fibres due to Apoptosis. In this study we have analyzed muscle cell death in vitro utilizing C2C12 myoblasts and myotubes, inducing Apoptosis by means of UVB irradiation. C2C12 cells were analysed by scanning and transmission electron microscopy (SEM, TEM) as well as by TUNEL reaction. DNA analysis was performed by gel electrophoresis and flow cytometry. MitoTracker red CMXRos and JC-1 fluorescent probes were also used to study mitochondrial behavior. Finally, caspase activity was investigated by means of Western blot, while caspase-9 and -3 inhibitor effects by means of SEM. SEM showed the typical membrane blebbing while TEM revealed the characteristic chromatin condensation. The TUNEL reaction presented a certain positivity too. Apoptotic and non-apoptotic nuclei in the same myotube were identified both by TUNEL and TEM. Gel electrophoresis never showed oligonucleosomal DNA fragmentation, in agreement with the cell cycle analysis performed by flow cytometry which did not reveal a sharp subdiploid peak. Mitochondrial response to UVB was later investigated and a decrease in mitochondrial functionality appeared. Caspase-9 and -3 cleavage, and, consequently, the activation of the caspase cascade, was also demonstrated by Western blot. Moreover a decrease in apoptotic cell number was noted after caspase-9 and-3 inhibitor treatment. All these results indicated that UVB irradiation induces Apoptosis, both in myoblasts and in myotubes, the second being more resistant. DNA fragmentation, at least the nucleosomic type, does not occur. A certain double-strand cleavage appears in TUNEL analysis, as well as characteristic ultrastructural changes in chromatin.

Apoptosis of human colorectal carcinoma cells is induced by blocking hepatoma-derived growth factor.

Med Oncol. 2009 Nov 19;
Liao F, Dong W, Fan L

Hepatoma-derived growth factor (HDGF) is a novel multifunctional growth factor that elicits pleiotropic effects on biological processes such as lung remodeling and renal development. Recent studies demonstrated that HDGF is related to tumor proliferation, invasion, angiogenesis, and Apoptosis. However, the molecular mechanism of HDGF's involvement in Apoptosis remains to be clarified. In this study, we first analyze the role of HDGF in colorectal carcinoma (CRC) progression by immunohistochemistry. Then we used small interference RNA (HDGF-siRNA) to block HDGF and assessed its effect on inducing Apoptosis of CRC loVo cells. Apoptosis was detected using flow cytometry (FCM), DNA ladder analysis, and Hoechst 33258 staining. In addition, the expression levels of some Apoptosis-related proteins were examined by western blot. The result showed that HDGF expression gradually increased in the colorectal carcinogenesis process. Further studies demonstrated that knock-down of HDGF can down-regulate the survivin, activate the mitochondrial pathway, and induce Apoptosis in loVo cells. These findings suggest that HDGF is involved in colorectal carcinogenesis process. Further blocking HDGF exhibits potent pro-apoptotic properties in colon cancer cells. Thus, HDGF might be a potential therapeutic target for human colorectal cancer. These findings may have major implications in the treatment of colorectal cancer.

Neuronal Nitric Oxide Synthase is a Key Factor in Doxorubicin-Induced Toxicity to Rat-Isolated Cortical Neurons.

Neurotox Res. 2009 Nov 19;
Lopes MA, Meisel A, Carvalho FD, de Lourdes Bastos M

Doxorubicin (DOX) is neurotoxic to serum-free cultures of rat cortical neurons in a biphasic concentration manner. For concentrations up to 0.5 muM, cell death follows an apoptotic pattern, while for higher concentrations Apoptosis is inhibited and necrosis becomes dominant. Considering the potential toxic effects of DOX resulting from its redox-cycling, in this study we investigated the generation of reactive species and subsequent oxidative stress effects, formation of quinoproteins, activation of NF-kB, depletion of energy levels and consequent cell death in cultures of primary rat cortical cells challenged with this antitumour drug. The influence of neuronal nitric oxide synthase (nNOS) on DOX-induced neuronal cell damage was subsequently evaluated. The exposure of rat cortical primary cell cultures to DOX resulted in a significant generation of ROS/RNS, activation of NF-kB, depletion of GSH levels, depletion of ATP, and cell death, in a concentration biphasic manner. Doxorubicin also significantly increased protein-bound quinone products in neurons in a concentration-dependent manner. Inhibition of nNOS decreased neuronal cell death induced by DOX in a significant way, at the first phase of the biphasic curve. In conclusion, this study shows, for the first time, a clear involvement of nNOS and subsequent ROS/RNS generation as crucial signalling mediators of DOX-induced neurotoxicity on isolated cortical neurons. Inhibition of ROS/RNS formation, modulation of NOS isoforms and modulation of NF-kB activation could be of beneficial in preventing damage in the CNS caused by DOX.

Polymorphisms of the Apoptosis-associated gene DP1L1 (deleted in polyposis 1-like 1) in colon cancer and inflammatory bowel disease.

J Cancer Res Clin Oncol. 2009 Nov 19;
Wellmann A, Fogt F, Hollerbach S, Hahne J, Koenig-Hoffmann K, Smeets D, Brinkmann U

PURPOSE: The deleted-in-polyposis1-like1 (DP1L1) gene displays pro-apoptotic activity and was proposed to be a tumor suppressor. It locates on chromosome 19p13.3, which harbors the locus for Peutz-Jeghers-Syndrome and is deleted in various tumors. We analyzed the association of DP1L1 polymorphisms with colon cancer, and cancer-associated Ulcerative colitis and Crohn's disease. EXPERIMENTAL DESIGN: Fifty-eight patients with colon cancer, 18 with Ulcerative colitis, 18 with Crohn's disease, and 70 control individuals were genotyped for SNPs at positions 992 and 996 of DP1L1 cDNA. RESULTS: Homozygous carriers of 992A alleles comprised 16% of the control group but were significantly increased in colon cancer with a frequency of 36% (P = 0.013 cancer vs control). Homozygous 991-A was also elevated in Ulcerative colitis (N = 18) with a frequency of 33%. In contrast, 18 patients with Crohn's disease showed no difference in frequency of 992AA (22%) compared to control. The A-allele of the adjacent C996A polymorphism has a low frequency (3.5%) in the control population, but significantly increased frequency of 13% in colon cancer (P = 0.0149 for allele frequency, Fisher's exact). 996-A allele frequency is also increased in inflammatory bowel disease (IBD): 22% of Ulcerative colitis- and 50% of Crohn's disease-patients were heterozygous carriers of 996-A (P = 0.052 for CU and P < 0.0001 for MC vs controls). CONCLUSIONS: DP1L1 polymorphisms are associated with colon cancer and IBD. This indicates that DP1L1 plays a functional role in these conditions. Thus DP1L1 may be a diagnostic and therapeutic target for colon cancer and IBD.

Histopathology of septic shock induced acute kidney injury: Apoptosis and leukocytic infiltration.

Intensive Care Med. 2009 Nov 19;
Lerolle N, Nochy D, Guérot E, Bruneval P, Fagon JY, Diehl JL, Hill G

PURPOSE: Septic shock is one of the leading causes of acute kidney injury. The mechanisms of this injury remain mostly unknown notably because of the lack of data on renal histological lesions in humans. METHODS: Kidney biopsy was performed immediately post-mortem in consecutive patients who died of septic shock. Comparisons were made with specimens from eight patients who died of trauma on scene and nine ICU patients that died of non-septic causes. RESULTS: Nineteen septic patients were included, 11 were male, and age was 72 +/- 12 years. Anuria occurred in all patients 2.2 +/- 1.4 days before death. Seven patients had disseminated intravascular coagulation. In all patients we observed (1) acute tubular lesions whose intensity correlated with blood lactate concentration; (2) intense infiltration by leukocytes, mainly monocytic, in glomeruli and interstitial capillaries as compared to controls; (3) presence of tubular cell Apoptosis proved by the presence of apoptotic bodies (2.9% of tubular cells) significantly more frequently than in controls and confirmed by TUNEL and activated caspase-3 staining. Arteriolar/arterial thromboses were observed in only 4 of 19 patients, without any association with presence of disseminated intravascular coagulation. CONCLUSIONS: Kidney lesions in septic shock go beyond those associated with simple acute tubular injury, notably capillary leukocytic infiltration and Apoptosis. Vascular thrombosis, however, did not appear to play a major role in the majority of patients. The extent to which these lesions are specific to sepsis or are common to all multi-organ failure independent of its cause is yet to be elucidated.

Septic acute kidney injury and tubular Apoptosis: never a Lone Ranger.

Intensive Care Med. 2009 Nov 19;
Joannes-Boyau O, Honoré PM, Boer W, Rose T

Effects of cigarette smoke extract on A549 cells and human lung fibroblasts treated with transforming growth factor-beta1 in a coculture system.

Clin Exp Med. 2009 Nov 19;
Liu Y, Gao W, Zhang D

Smoking is a risk factor for idiopathic pulmonary fibrosis (IPF), but the mechanism of the association remains unknown. The aim of this study was to investigate the effects of cigarette smoke extract (CSE) on A549 cells and human lung fibroblasts treated with transforming growth factor-beta1. A transwell two-chamber coculture system was used to study the proliferation, differentiation, morphologic changes and soluble factors production of A549 cells and myofibroblasts. Low concentrations of CSE promoted myofibroblasts proliferation; however, high concentrations of CSE inhibited their proliferation. Low concentrations of CSE also markedly increased extracellular secretion of hydrogen peroxide, inhibited proliferation, induced Apoptosis and produced epithelial-mesenchymal transition (EMT) in cocultured A549 cells. This cigarette smoke-induced A549 cells EMT may become a new pathophysiological concept in the development of IPF. CSE possibly takes part in the development and progress of IPF by increasing oxidative stress.

The role of endoplasmic reticulum stress in the early stage of diabetic retinopathy.

Acta Diabetol. 2009 Nov 19;
Li B, Wang HS, Li GG, Zhao MJ, Zhao MH

The aim of this study was to evaluate the role of endoplasmic reticulum (ER) stress in diabetic retinopathy (DR) using in vitro and in vivo models. For the in vivo studies, diabetes was induced in rats, and retinal expression of glucose-regulated protein 78 (GRP78), activating transcription factor 4 (ATF4), C/EBP homologous protein (CHOP), and vascular endothelial growth factor (VEGF) in groups of rats at 1, 3, and 6 months was assessed. For the in vitro studies, human retinal capillary endothelial cells (HRCECs) were cultured in the presence of varying glucose concentrations, and the expression of mRNA and protein for GRP78, ATF4, CHOP, and VEGF was assessed. The chosen glucose concentrations were reflective of those apparent in diabetic patients. Expression of VEGF and CHOP mRNA levels were significantly increased in diabetic rats compared to control rats at 1, 3, and 6 months (P < 0.05). In HRCECs cultured in the presence of high as well as variable glucose concentrations, CHOP expression and Apoptosis were significantly increased (P < 0.05). However, GRP78 and ATF4 expression levels were unchanged. Our findings suggest that early progression of DR may be mediated by ER stress, but probably does not involve changes in ATF4 or GRP78.

Transcriptional Regulation and Biological Functions of Selenium-Binding Protein 1 in Colorectal Cancer In Vitro and in Nude Mouse Xenografts.

PLoS One. 2009; 4(11): e7774
Pohl NM, Tong C, Fang W, Bi X, Li T, Yang W

BACKGROUND: It has been shown that selenium-binding protein 1 (SBP1) is significantly downregulated in different human cancers. Its regulation and function have not yet been established. METHODOLOGY AND PRINCIPAL FINDINGS: We show that the SBP1 promoter is hypermethylated in colon cancer tissues and human colon cancer cells. Treatment with 5'-Aza-2'-deoxycytidine leads to demethylation of the SBP1 promoter and to an increase of SBP1 promoter activity, rescues SBP1 mRNA and protein expression in human colon cancer cells. Additionally, overexpression of SBP1 sensitizes colon cancer cells to H(2)O(2)-induced Apoptosis, inhibits cancer cell migration in vitro and inhibits tumor growth in nude mice. CONCLUSION AND SIGNIFICANCE: These data demonstrate that SBP1 has tumor suppressor functions that are inhibited in colorectal cancer through epigenetic silencing.

Acadesine Kills Chronic Myelogenous Leukemia (CML) Cells through PKC-Dependent Induction of Autophagic Cell Death.

PLoS One. 2009; 4(11): e7889
Robert G, Ben Sahra I, Puissant A, Colosetti P, Belhacene N, Gounon P, Hofman P, Bost F, Cassuto JP, Auberger P

CML is an hematopoietic stem cell disease characterized by the t(9;22) (q34;q11) translocation encoding the oncoprotein p210BCR-ABL. The effect of acadesine (AICAR, 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside) a compound with known antileukemic effect on B cell chronic lymphoblastic leukemia (B-CLL) was investigated in different CML cell lines. Acadesine triggered loss of cell metabolism in K562, LAMA-84 and JURL-MK1 and was also effective in killing imatinib-resistant K562 cells and Ba/F3 cells carrying the T315I-BCR-ABL mutation. The anti-leukemic effect of acadesine did not involve Apoptosis but required rather induction of autophagic cell death. AMPK knock-down by Sh-RNA failed to prevent the effect of acadesine, indicating an AMPK-independent mechanism. The effect of acadesine was abrogated by GF109203X and Ro-32-0432, both inhibitor of classical and new PKCs and accordingly, acadesine triggered relocation and activation of several PKC isoforms in K562 cells. In addition, this compound exhibited a potent anti-leukemic effect in clonogenic assays of CML cells in methyl cellulose and in a xenograft model of K562 cells in nude mice. In conclusion, our work identifies an original and unexpected mechanism by which acadesine triggers autophagic cell death through PKC activation. Therefore, in addition to its promising effects in B-CLL, acadesine might also be beneficial for Imatinib-resistant CML patients.

Heat stress triggers Apoptosis by impairing NF-kappaB survival signaling in malignant B cells.

Leukemia. 2009 Nov 19;
Belardo G, Piva R, Santoro MG

Nuclear factor-kappaB (NF-kappaB) is involved in multiple aspects of oncogenesis and controls cancer cell survival by promoting anti-apoptotic gene expression. The constitutive activation of NF-kappaB in several types of cancers, including hematological malignancies, has been implicated in the resistance to chemo- and radiation therapy. We have previously reported that cytokine- or virus-induced NF-kappaB activation is inhibited by chemical and physical inducers of the heat shock response (HSR). In this study we show that heat stress inhibits constitutive NF-kappaB DNA-binding activity in different types of B-cell malignancies, including multiple myeloma, activated B-cell-like (ABC) type of diffuse large B-cell lymphoma (DLBCL) and Burkitt's lymphoma presenting aberrant NF-kappaB regulation. Heat-induced NF-kappaB inhibition leads to rapid downregulation of the anti-apoptotic protein cellular inhibitor-of-Apoptosis protein 2 (cIAP-2), followed by activation of caspase-3 and cleavage of the caspase-3 substrate poly(adenosine diphosphate ribose)polymerase (PARP), causing massive Apoptosis under conditions that do not affect viability in cells not presenting NF-kappaB aberrations. NF-kappaB inhibition by the proteasome inhibitor bortezomib and by short-hairpin RNA (shRNA) interference results in increased sensitivity of HS-Sultan B-cell lymphoma to hyperthermic stress. Altogether, the results indicate that aggressive B-cell malignancies presenting constitutive NF-kappaB activity are sensitive to heat-induced Apoptosis, and suggest that aberrant NF-kappaB regulation may be a marker of heat stress sensitivity in cancer cells.Leukemia advance online publication, 19 November 2009; doi:10.1038/leu.2009.227.

Cathepsin B release after imatinib-mediated lysosomal membrane permeabilization triggers BCR-ABL cleavage and elimination of chronic myelogenous leukemia cells.

Leukemia. 2009 Nov 19;
Puissant A, Colosetti P, Robert G, Cassuto JP, Raynaud S, Auberger P

Imatinib is the leading compound to treat patients with chronic myelogenous leukemia (CML) but the exact mechanism of its anti-leukemic effect is incompletely elucidated. Through inhibition of BCR-ABL, Imatinib blocks several downstream pathways and induces Apoptosis of BCR-ABL positive cells. In this study, we analyzed further the mode of action of Imatinib in different appropriate cellular models of CML either sensitive or resistant to Imatinib and in CD34+ cells from CML patients. Pharmacological or short hairpin RNA-mediated inhibition of BCR-ABL triggers lysosomal membrane permeabilization (LMP) that culminates in activation and redistribution of Cathepsin B (CB) into the cytoplasm of CML cells, in which it triggers directly BCR-ABL degradation. Pharmacological inhibition of CB by CA-074Me or small interfering RNA-mediated knock-down of CB partly protects K562 cells from Imatinib-induced cell death and CB overexpression sensitizes these cells to Imatinib killing. Strikingly, Imatinib-triggered LMP, CB activation and BCR-ABL cleavage in CD34+ cells from CML patients and inhibition of CB confers protection against cell death in clonogenic assays of CD34+ primary cells from CML patients. Hence, we describe an original pathway by which Imatinib participates to the elimination of CML cells through LMP and CB-mediated specific degradation of BCR-ABL.Leukemia advance online publication, 19 November 2009; doi:10.1038/leu.2009.233.

ADENOSINE A2A RECEPTOR SELECTIVE STIMULATION REDUCES SIGNALING PATHWAYS INVOLVED IN THE DEVELOPMENT OF INTESTINE ISCHEMIA AND REPERFUSION INJURY.

Shock. 2009 Nov 17;
Di Paola R, Melani A, Esposito E, Mazzon E, Paterniti I, Bramanti P, Pedata F, Cuzzocrea S

In the present study, we tested the efficacy of treatment with the selective adenosine A2A receptor agonist 2-[ p-(2-carboxyethyl)phenylethylamino]-50-ethylcarboxamidoadenosine (CGS 21680) on ischemia and reperfusion injury of the multivisceral organs.Ischemia and reperfusion injury was induced in mice by clamping both the superior mesenteric artery and the celiac artery for 30 min, followed thereafter by reperfusion. Sixty minutes after reperfusion, animals were sacrificed for histological examination and biochemical studies. Injured vehicle-treated mice developed a significant increase of ileum TNF-alphalevels, myeloperoxidase activity and marked histological injury and Apoptosis. Ischemia and reperfusion injury of the multivisceral organs was also associated with a significant mortality. Reperfused ileum sections from injured vehicle-treated mice showed positive staining for P-selectin and ICAM-1.The intensity and degree of P-selectin and ICAM-1 were markedly reduced in tissue section from injured- CGS 21680 treated mice. Ischemia and reperfusion injured mice which have been treated with CGS 21680 showed also a significant reduction of neutrophil infiltration into the intestine, a reduction of Apoptosis, an improved histological status of the intestine and survival.Taken together, our results clearly demonstrate that selective activation of adenosine A2A receptors play an important role in the regulation of ischemia and reperfusion injury and put forward the hypothesis that selective activation of adenosine A2A receptors may represent a novel and possible strategy.

Autophagy augmented by troglitazone is independent of EGFR transactivation and correlated with AMP-activated protein kinase signaling.

Autophagy. 2010 Jan 27; 6(1):
Yan J, Yang H, Wang G, Sun L, Zhou Y, Guo Y, Xi Z, Jiang X

Troglitazone is a synthetic ligand of peroxisome proliferators activated receptor-gamma (PPARgamma) and induces Apoptosis in a variety of malignant cells. However, the underlying mechanism of its regulatory role in macroautophagy (hereafter autophagy) remains largely unknown. Using fluorescence and electron microscopy, we observed that autophagosomes could be induced and identified upon troglitazone challenge in both primary and epidermal growth factor receptor (EGFR)-expressed porcine aortic endothelial (PAE) cells. We report here that troglitazone augments AMP-activated protein kinase-alpha (AMPKalpha) phosphorylation, reduces p70S6 kinase phosphorylation and stimulates autophagy that is independent of EGFR expression and transactivation. Troglitazone stimulus reduced neither lysosomal staining nor GFP-LC3 dots of HeLa cells, when the cells pretreated with AG1478, a specific EGFR kinase inhibitor. Furthermore, AG1478 additively enhanced the troglitazone-induced degradation of sequestosome 1 (SQSTM1/p62), which is a selective substrate of autophagy. Inhibition of AMPKalpha activity either by compound C or by RNA interference markedly reduced the accumulation of microtubule-associated protein 1 light chain 3-II (LC3-II ), a good indicator of autophagy; whereas blockage of PPARgamma activity by the irreversible antagonist GW9662 or by overexpressing dominate-negative PPARgamma did not affect LC3-II accumulation and AMPK phosphorylation. Taken together, we demonstrate that autophagy promoted via troglitazone is correlated with AMPKalpha activation and independent of PPARgamma activation and EGFR transactivation.

Marchantin C: A potential anti-invasion agent in glioma cells.

Cancer Biol Ther. 2010 Jan 9; 9(1):
Shen J, Li G, Liu Q, He Q, Gu J, Shi Y, Lou H

Cancer cell migration is a leading cause of tumor recurrence and treatment failure. Previously, we reported that marchantin C exhibited promising antitumor activity by inducing microtubule depolymerization and Apoptosis. In the present study, we investigated the effect of marchantin C on inhibition of migration in T98G and U87 cells. The scratch-induced migration, Boyden chamber and cell invasion assays were applied to determine that the migrating capacity and invasiveness of these glioma cell lines were inhibited when exposed to marchantin C at a low concentration. There are no obvious signs of Apoptosis with this dose. Western blot analyses confirmed that MMP-2, a key role in cancer cell migration, was reduced after incubation with marchantin C in both glioma cell lines. In addition, signaling pathway investigations demonstrated that ERK/MAPK might be involved in MMP-2 downregulation, rather than the AKT/PI3K or JAK/STAT3 pathways. Moreover, marchantin C potently suppressed angiogenesis activity in vivo by CAM assay. This is the first study to demonstrate that marchantin C can inhibit glioma cell migration and invasiveness.

Targeting HER2 signaling pathway for radiosensitization: Alternative strategy for therapeutic resistance.

Cancer Biol Ther. 2009 Dec 19; 8(24):
No M, Choi EJ, Kim IA

Several studies have indicated the potential value of targeting HER-2 signaling to enhance the anti-tumor activity of ionizing radiation. However, therapeutic resistance resulting from several factors, including activation of the downstream pathway, represents a major obstacle to treatment. Here, we investigated whether inhibitors targeting downstream of HER-2 signaling would radiosensitize SKBR3 breast cancer cells that exhibit overamplification of HER2. Selective inhibition of MEK-ERK signaling using pharmacologic inhibitors (PD98059, UO126) did not increase the radiosensitivity of SKBR3 cells. Selective inhibition of the PI3K-AKT-mTOR pathway using pharmacologic inhibitors (LY294002, AKT inhibitor VIII, Rapamycin) significantly attenuated expression of p-AKT and p-70S6K, respectively and radiosensitized SKBR3 cells. MCF-7 cells those did not overexpress HER-2, showed less radiosensitization compared to SKBR3 cells by inhibition of this pathway. Pre-treatment with these inhibitors also caused significant abrogation of typical G(2) arrest following ionizing radiation and induced marked prolongation of gammaH2AX foci indicating impairment of DNA damage repair. A dual inhibitor of Class I PI3K and mTOR, PI103 effectively radiosensitized SKBR3 cells and showed significant prolongation of gammaH2AX foci. Inhibition of PI3K-AKT signaling was associated with downregulation of DNA-PKs, respectively. While Apoptosis was the major mode of cell death when the cells were pretreated with LY294002 or AKT inhibitor VIII, the cells were pretreated by rapamycin or PI103 showed mixed mode of cell death including autophagy. Our results suggest possible mechanisms to counteract the HER-2 prosurvival signaling implicated in radioresistance, and offer an alternative strategy to overcome resistance to HER-2 inhibitors combined with radiation.

CXCL12/CXCR4 promotes motility and proliferation of glioma cells.

Cancer Biol Ther. 2010 Jan 17; 9(1):
do Carmo A, Patricio I, Cruz MT, Carvalheiro H, Oliveira CR, Lopes MC

Glioblastoma (GBM) is the most aggressive and malignant brain tumor. Recent studies indicated that glioma samples are characterized by increased expression of CXCR4, the CXCL12/SDF-1 chemokine receptor. To better understand the role of CXCR4 in GBM biology we performed an integrated study where we simultaneously evaluate the contribution of the CXCR4/CXCL12 signaling pathway to the proliferation, survival and motility of a human GBM cell line. Our results indicated that CXCR4/CXCL12 axis induced an increase in cell proliferation and in cell motility. The blockage of CXCR4 induced a significant increase of Apoptosis. Together, our results indicated that CXCR4/CXCL12 signalling pathway may contribute to GBM development and emphasize the therapeutic potential of this pathway in patients with GBM.

Self-killing of melanoma cells by cytosolic delivery of dsRNA: Wiring innate immunity for a coordinated mobilization of endosomes, autophagosomes and the apoptotic machinery in tumor cells.

Autophagy. 2010 Jan 29; 6(1):
Alonso-Curbelo D, Soengas MS

Patients with metastatic melanoma have a poor prognosis, primarily due to a generalized inefficacy of current anticancer treatments. Therefore, the identification of novel death inducers with good bioavailability and safety profiles is a main priority in this disease. Here we summarize recent work from our group uncovering an unexpected ability of the dsRNA mimic polyinosine-polycytidylic acid (pIC) to engage the endo/lysosomal machinery of melanoma cells and induce their self degradation by autophagy and Apoptosis, without noticeable secondary effects in vivo. However the antimelanoma activity of pIC strictly required conjugation with carriers (e.g., polyethyleneimine, PEI) for cytosolic delivery. Combining transcriptome analyses with RNA interference, we found RNA helicase MDA-5 as a main driver of the pIC-PEI complex. MDA-5 in turn, favored NOXA-dependent activation of apoptotic caspases. These results demonstrate new therapeutically tractable links between autophagy and Apoptosis that can be coordinately engaged in tumor cells by dsRNA mimics.